anonymous
Guest
anonymous
Guest
Sun India either thinks it has been successful in the US or knows that it has lost. Here is Dilip’s own words:
https://wap.business-standard.com/a...n-pharma-s-dilip-shanghvi-119050500659_1.html
With recovery underway in the US market, where it has already readied a specialty drugs pipeline, DILIP SHANGHVI, founder and managing director, Sun Pharmaceutical Industries, tells Sohini Das he is now focusing on China and Japan. While he feels the domestic market is big enough to accommodate both branded and unbranded medicines, Shanghvi nonetheless states that government intervention in drug pricing is a global challenge.
https://wap.business-standard.com/a...n-pharma-s-dilip-shanghvi-119050500659_1.html